
Pharnext: Shareholders approve the appointment of Guy-Charles Fanneau de La Horie to the Supervisory Board
By Hector Chaunu Published on 07/10/2023 at 08:47 Photo credit © ChaunuPictures (Boursier.com) — Pharnext a biopharmaceutical company at an advanced clinical stage developing new therapies for neurodegenerative diseases with no satisfactory therapeutic solution, announces today the appointment of Guy-Charles Fanneau de La…